LANDONI, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 20.041
AS - Asia 12.827
EU - Europa 9.175
SA - Sud America 2.062
AF - Africa 306
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 13
Totale 44.458
Nazione #
US - Stati Uniti d'America 18.502
SG - Singapore 4.997
IT - Italia 2.749
CN - Cina 2.198
HK - Hong Kong 2.094
RU - Federazione Russa 1.673
BR - Brasile 1.577
VN - Vietnam 1.521
CA - Canada 1.334
SE - Svezia 973
IE - Irlanda 933
DE - Germania 890
BD - Bangladesh 434
FR - Francia 408
UA - Ucraina 382
IN - India 377
GB - Regno Unito 351
FI - Finlandia 202
AR - Argentina 182
ID - Indonesia 160
KR - Corea 153
IQ - Iraq 141
TR - Turchia 133
MX - Messico 119
ZA - Sudafrica 114
NL - Olanda 106
AT - Austria 98
ES - Italia 97
JP - Giappone 89
PK - Pakistan 81
SA - Arabia Saudita 72
CO - Colombia 66
PH - Filippine 64
EC - Ecuador 60
VE - Venezuela 60
PL - Polonia 53
UZ - Uzbekistan 44
CH - Svizzera 41
DK - Danimarca 41
MA - Marocco 37
CL - Cile 34
PY - Paraguay 34
EG - Egitto 30
AU - Australia 27
MY - Malesia 27
TN - Tunisia 26
AE - Emirati Arabi Uniti 25
BE - Belgio 25
KE - Kenya 25
SK - Slovacchia (Repubblica Slovacca) 23
PE - Perù 22
RO - Romania 20
IL - Israele 18
JM - Giamaica 18
JO - Giordania 18
AZ - Azerbaigian 17
IR - Iran 17
UY - Uruguay 17
PS - Palestinian Territory 16
CR - Costa Rica 15
CZ - Repubblica Ceca 15
LT - Lituania 15
OM - Oman 15
DZ - Algeria 14
ET - Etiopia 14
NP - Nepal 14
TH - Thailandia 14
KZ - Kazakistan 13
NG - Nigeria 13
AL - Albania 12
HN - Honduras 11
LB - Libano 11
TW - Taiwan 11
BG - Bulgaria 10
BO - Bolivia 10
RS - Serbia 10
KG - Kirghizistan 9
PT - Portogallo 9
DO - Repubblica Dominicana 8
EU - Europa 8
PA - Panama 8
KW - Kuwait 7
MN - Mongolia 7
NI - Nicaragua 7
AO - Angola 6
HR - Croazia 6
SN - Senegal 6
BY - Bielorussia 5
GE - Georgia 5
HU - Ungheria 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
TT - Trinidad e Tobago 5
BB - Barbados 4
BH - Bahrain 4
GR - Grecia 4
MU - Mauritius 4
NO - Norvegia 4
QA - Qatar 4
A2 - ???statistics.table.value.countryCode.A2??? 3
Totale 44.400
Città #
Singapore 2.943
Ann Arbor 2.072
Hong Kong 2.053
Ashburn 1.804
Fairfield 1.397
Toronto 1.156
San Jose 1.091
Woodbridge 964
Dublin 894
Milan 820
Houston 780
Wilmington 691
Chandler 636
New York 599
Santa Clara 568
Seattle 517
Cambridge 501
Frankfurt am Main 464
Chicago 443
Princeton 442
Ho Chi Minh City 395
Beijing 350
The Dalles 321
Hanoi 312
Los Angeles 308
Jacksonville 298
Dearborn 277
Hefei 267
Rome 238
Lauterbourg 236
Dallas 220
Lawrence 197
Boardman 185
Altamura 167
São Paulo 148
Moscow 145
Seoul 144
Buffalo 133
Helsinki 126
San Diego 119
Nanjing 106
Shanghai 103
Jakarta 96
London 92
Dong Ket 89
Council Bluffs 87
Guangzhou 85
Andover 82
Hamburg 75
Munich 74
Tokyo 64
Nuremberg 61
Vienna 60
Fremont 59
Haiphong 58
Rio de Janeiro 57
Atlanta 56
Baghdad 56
Chennai 51
Salt Lake City 51
Da Nang 50
Orem 50
Mumbai 47
Johannesburg 44
Montreal 44
Turin 43
Brooklyn 42
Dhaka 41
Lachine 41
Curitiba 40
Naples 40
Tashkent 40
Phoenix 39
Bologna 38
Tianjin 38
Warsaw 34
Biên Hòa 33
Norwalk 33
Denver 31
Brasília 30
Lissone 30
Washington 30
Falls Church 29
Nanchang 29
Boston 28
Figino 28
Pune 28
Shenyang 28
Florence 26
Riyadh 26
San Francisco 26
Stockholm 26
Amsterdam 25
Porto Alegre 25
Changsha 24
Elk Grove Village 24
Manchester 24
Monza 24
Tampa 24
Jinan 23
Totale 28.208
Nome #
High-dose epirubicin in patients with advanced or recurrent uterine sarcoma 580
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 542
Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3 475
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 449
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms 436
Genomic and epigenomic profile of uterine smooth muscle tumors of uncertain malignant potential (Stumps) revealed similarities and differences with leiomyomas and leiomyosarcomas 408
Prevalence of human papillomavirus (HPV) and other sexually transmitted infections (STIS) among italian women referred for a colposcopy 396
Erratum: Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (Annals of Oncology (2017) 28 (iv72-iv83) DOI: 10.1093/annonc/mdx220) 388
Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis 372
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers 363
Standard ultra-staging compared to one-step nucleic acid amplification for the detection of sentinel lymph node metastasis in endometrial cancer patients: a retrospective cohort comparison 361
Clinical outcome of patients with malignant tumors associated with mature cystic teratomas of the ovary: A retrospective multicenter Italian study 357
Two ultrastaging protocols for the detection of lymph node metastases in early-stage cervical and endometrial cancers 346
An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective 326
The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis 315
Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer 312
The impact of the type of nodal assessment on prognosis in patients with high-intermediate and high-risk ESMO/ESGO/ESTRO group endometrial cancer. A multicenter Italian study 311
European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer 307
Imact of bevacizumab-containing primary treatment on outcome of recurrent ovarian cancer: An Italian study 301
Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: A prospective randomized study 287
Lymph node evaluation in high-risk early stage endometrial cancer: A multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy 286
Prevalence of Chlamydia trachomatis Infection, Serovar Distribution and Co-Infections with Seven High-Risk HPV Types among Italian Women with a Recent History of Abnormal Cervical Cytology 285
Dose-dense neoadjuvant chemotherapy with paclitaxel and carboplatin in cervical cancer: Efficacy on pathological response 273
The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy 272
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 271
The clinical significance of the tumor marker CA-125 265
Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial 263
Uterine leiomyosarcoma: analysis of treatment failures and survival 260
Onclarity Human Papillomavirus Extended Genotyping in the Management of Cervical Intraepithelial Neoplasia 2+ Lesions 256
Evaluation of Human Papilloma Virus (HPV) Genotyping and Viral Load Determination as Diagnostic Biomarkers of Cervical Cancer Risk 255
Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy 252
Accuracy of Human Papillomavirus (HPV) Testing on Urine and Vaginal Self-Samples Compared to Clinician-Collected Cervical Sample in Women Referred to Colposcopy 250
Association between physical activity and menstrual cycle disorders in young athletes 249
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study 247
Borderline ovarian cancer 243
Molecular Detection of Human Papillomavirus (HPV) and Other Sexually Transmitted Pathogens in Cervical and Self-Collected Specimens 242
Neoadjuvant platinum-based chemotherapy followed by radical hysterectomy for stage Ib2-IIb adenocarcinoma of the uterine cervix – An Italian multicenter retrospective study 242
Fertility outcomes in stage I ovarian immature teratomas 241
Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma 239
Cisplatin-, epirubicin- and paclitaxel-containing chemotherapy in uterine adenocarcinoma 234
Evaluation of two alternative non-alcohol-based media for the suspension of self-collected vaginal swabs for HPV testing in cervical cancer screening 233
Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer 232
Copy number alterations in stage I epithelial ovarian cancer highlight three genomic patterns associated with prognosis 227
Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study 226
Evaluation of BD Onclarity™ HPV Assay on Self-Collected Vaginal and First-Void Urine Samples as Compared to Clinician-Collected Cervical Samples: A Pilot Study 225
Endometrial stromal sarcoma: analysis of treatment failures and survival 225
Neoadjuvant chemotherapy followed by radical surgery in locally advanced vulvar carcinoma: a single-institution experience 221
Diffusion-weighted MR imaging in assessing cervical tumour response to nonsurgical therapy 221
Neoadjuvant chemotherapy prior to pelvic exenteration in patients with recurrent cervical cancer: Single institution experience 221
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer 221
Cancer in pregnancy: Proposal of an italian multicenter study. gynecologic oncology group of the italian society of gynecology and obstetrics (sigo) 220
Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: Results from a multi-institutional study 220
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 219
A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study 219
Brachytherapy for isolated vaginal recurrences from endometrial carcinoma 218
Platinum-based neoadjuvant chemotherapy followed by radical surgery for cervical carcinoma international federation of gynecology and obstetrics stage IB2-IIB 217
Robotic Surgery: Changing the Surgical Approach for Endometrial Cancer in a Referral Cancer Center 215
Chemo-conization in early cervical cancer 215
Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy 215
Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer 214
Risk-reducing salpingo-oophorectomy in women at higher risk of ovarian and breast cancer: A single institution prospective series 214
Clinical correlates of in vitro drug sensitivities of ovarian cancer cells 212
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 212
Anatomical Spaces in Radical Hysterectomy for Cervical Cancer 209
Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients 209
Early oral versus "traditional" postoperative feeding in gynecologic oncology patients undergoing intestinal resection: A randomized controlled trial 208
European society of gynaecological oncology guidelines for the management of patients with Vulvar cancer 207
Cisplatin, vinblastine, and bleomycin combination chemotherapy in metastatic granulosa cell tumor of the ovary 204
Reduction of postoperative complication rate with the use of early oral feeding in gynecologic oncologic patients undergoing a Major surgery: A randomized controlled trial 204
Intense neoadjuvant chemotherapy with cisplatin and epirubicin for advanced or bulky cervical and vaginal adenocarcinoma 203
The clinical implementation of primary HPV screening 203
Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis 202
Procoagulant and fibrinolytic activity of human ovarian carcinoma cells in culture 202
Radical Hysterectomy in Early-Stage Cervical Cancer: Abandoning the One-Fits-All Concept 201
Low-Volume Metastases in Cervical Cancer: Does Size Matter? 201
Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study 200
Fertility-Sparing Options in Young Women with Cervical Cancer 199
Pre-chemotherapy hemoglobin levels and survival in patients with advanced epithelial ovarian cancer who received a first-line taxane/platinum-based regimen: Results of a multicenter retrospective Italian study 198
DNA index of ovarian carcinomas from 56 patients: In vivo in vitro studies 198
Oncologic and fertility outcomes in patients with juvenile granulosa cell tumor - a retrospective single centre analysis 196
Endometriosis-related spontaneous hemoperitoneum in pregnancy: A case series 195
Advanced low grade serous ovarian cancer: A retrospective analysis of surgical and chemotherapeutic management in two high volume oncological centers 195
Adult primary cervical rhabdomyosarcomas: A Multicentric cross-national case series 193
Chlamydia trachomatis infection and HPV/Chlamydia trachomatis co-infection among HPV-vaccinated young women at the beginning of their sexual activity 192
Eviscerazione pelvica 191
Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer 189
Teniposide in refractory ovarian cancer: a phase II study 189
Randomized study between radical surgery and radiotherapy for the treatment of stage IB–IIA cervical cancer: 20-year update 189
The prognosis of stage IA cervical cancer: Subgroup analysis of the SCCAN study 188
Genomic instability analysis in DNA from Papanicolaou test provides proof-of-principle early diagnosis of high-grade serous ovarian cancer 187
Effectiveness of autologous blood transfusion in patients undergoing radical hysterectomy 187
Low-Volume Metastases in Apparent Early-Stage Endometrial Cancer: Prevalence, Clinical Significance, and Future Perspectives 187
Colposcopy Accuracy and Diagnostic Performance: A Quality Control and Quality Assurance Survey in Italian Tertiary-Level Teaching and Academic Institutions—The Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV) 184
Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experience 184
The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer 182
Repair of the Perineal Defect After Radical Vulvar Surgery: Direct Closure Versus Skin Flaps Reconstruction: A Retrospective Comparative Study 181
Mitozolomide activity on human cancer cells in vitro 180
Multidisciplinary approach in the management of advanced ovarian cancer patients: A personalized approach. Results from a specialized ovarian cancer unit 179
Pelvic exenteration: Ten-year experience at the European Institute of Oncology in Milan 177
DNA interstrand cross-links induced by cis-dichlorodiammine platinum in ovarian cancer cells growing in primary culture 177
Totale 24.989
Categoria #
all - tutte 163.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 163.106


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021406 0 0 0 0 0 0 0 0 0 0 0 406
2021/20222.661 162 322 368 170 160 164 127 169 129 199 212 479
2022/20233.348 477 912 250 221 228 561 58 172 254 32 90 93
2023/20242.974 73 63 180 123 432 688 553 67 310 68 52 365
2024/20258.222 408 1.160 600 381 662 332 405 242 920 1.216 612 1.284
2025/202618.751 1.627 1.174 1.338 1.934 1.967 971 2.605 1.081 1.474 1.326 1.659 1.595
Totale 45.546